Rich Countries Seek Priority Access to COVID-19 Vaccine

In order for an eventual COVID-19 vaccine to save as many lives as possible, it would require rapid distribution, and to those countries struggling with the highest infection rates. The chances that will happen are slim, say several experts who see an increasingly competitive race for first-access to a potential vaccine.

“We have this beautiful picture of everyone getting the vaccine, but there is no road map on how to do it,” the Associated Press was told by Yuan Qiong Hu, a senior legal and policy adviser at Doctors Without Borders in Geneva.

Hu predicts that the existing structure, in which companies establish patents at every step of vaccine development, will hamper the distribution and development of a vaccine that could be made available to all. “We can’t afford to face these multiple layers of private rights to create a ‘people’s vaccine,’” she told the AP.

Three phases

Several possible vaccines are under development across the world thanks to global efforts, with around a dozen in the early stages of testing. Vaccine development requires any potential remedy to go through a three-phase process that tests the efficacy of the drug while ensuring that side effects do not pose unforeseen risks.

In the first phase, small groups of people receive the trial vaccine. If the vaccine proves successful without any significant health risks among the participants, the process moves to the second phase.

In phase two, the clinical study expands to a group of people who are part of the risk group for whom the vaccine is intended, which in COVID-19 cases would be older people and those vulnerable because of pre-existing illnesses.

The third and final phase tests the vaccine on thousands of people to ensure safety and a proven efficacy to avoid false positives and detect possible allergic reactions or side effects.

Private investment

Several wealthy countries have spent millions to support the rapid development of possible vaccine candidates and ensure a potential vaccine could be manufactured on a large scale. In exchange for these investments, these countries are expected to receive vaccines before others.

The British government has declared that the first 30 million doses of a possible vaccine under development at Oxford University will be earmarked for British citizens. The US became entangled in a diplomatic row with France over the potential future distribution of a French vaccine candidate to which the US expected first access because of its investments.

AstraZeneca, a drug manufacturer that intends to produce Oxford University’s vaccine, has signed an agreement with the US that would guarantee 300 million doses for the US, to be delivered as soon as possible.

The same manufacturer struck a deal with four EU countries to also supply them with 300 million doses. Drug manufacturers appear to be actively goading governments into making early commitments to buy yet-unproven drugs, playing countries against each other as they stand to make giant profits.

While pharmaceutical companies have pledged to provide a not-for-profit version of their vaccines, it is becoming clear that the world’s richest will be the first to receive the vaccines, even if other countries need them much more. Another example of the perverse nature of privatized medicine, it will be the richest, not the sickest, who will receive priority in this global crisis.

European Leaders Hide COVID-19 Deaths

Belgium has faced international criticism for its high COVID-19 death-rate, but Belgian scientists claim that the rest of the EU are under-counting or under-reporting fatalities.

Professor Steven van Gucht, head of Belgium’s scientific COVID-19 response team has been under fire from both national and international actors for using a counting method that the British Health Foundation describes as the “fairest way to compare COVID-19 deaths internationally.”

Van Gucht has felt the pressure from Belgium’s business community and political leadership who have urged him to change the method of counting, “but we refused,” van Gucht told Deutsche Welle. Infection rates appear to be slowing in Europe, allowing for a deeper look into the numbers behind the pandemic’s impact on Europe.

Excess Deaths

It now appears that Belgium is one of the few European countries that has accurately reported the scale of the crisis on its citizens, while most have downplayed their numbers. “Official covid-19 death tolls still under-count the true number of fatalities,” the Economist concluded when they compared “excess deaths,” the increase in deaths compared to a five-year average.

In Belgium, this April saw the most deaths since the country was under Nazi occupation. While many other countries will have reached similar milestones they have not been revealed because of the structural under-reporting by national leaders.

Despite the scrutiny and mistrust surrounding COVID-19 data from China and Iran, data presented by the “revered ladies and gentlemen” that rule Europe have received no such scrutiny. That was a mistake, new data reveals, as most European leaders appear to have downplayed thousands of deaths in their countries.

Systematic under-reporting

Between March 14 and May 15, Britain’s government reported 45,298 coronavirus-related deaths, while the true number appears to stand at 59,100, meaning that Boris Johnson’s government is not reporting almost one in every four deaths.

The Dutch “intelligent lock-down” apparently has been supported through less than complete numbers, as Prime Minister Mark Rutte has only reported 60% of the country’s death-toll, ignoring 3,745 fatalities out of a total death-toll of 9,405 between March 16 and May 17.

In Italy almost half of all COVID-19 deaths have not been reported as such, with the country’s official tally standing at 12,178 deaths between February 26 and March 31, while the real number appears to be 24,031. Based on the data provided by the Economist, besides Belgium, only France and Spain come close to reporting their actual numbers.

Why it matters

This systematic misinformation could have dire consequences as citizens do not see the true scale of the tragedy that has befallen their country, and will not hold their leaders to account.

The patchwork of different approaches across Europe appears to have developed a perverse competition over which country ‘outperformed’ the others, creating an incentive to downplay numbers.

As an example, Dutch Prime Minister Mark Rutte has been enjoying rising popularity for himself and his center-right party. Instead of facing criticism for the country’s failure to prevent the deaths of over 9,000 citizens in a single month, the Dutch appear to have been lulled into a false sense of confidence in their elected leaders.

As a result a government that failed to adequately prepare and wasted valuable time in implementing lock-downs will likely not face any political ramifications.

Little criticism has emerged over the government’s decision to allow a large-scale festival in the country’s southern provinces while Italy was already implementing its first lockdown in Lombardy. Within a month it became clear the decision had led to a large outbreak in the country’s south.

Weeks later the Dutch PM still upheld that the country was in the “containment phase” and was touting “herd immunity” as a strategy even as thousands had already become infected. On March 21, Dutch health officials were shipping patients to northern provinces as hospitals in the south were flooded by COVID-19 patients in need of intensive care.

Consequences

By the end of March the number of cases was doubling every week and health officials announced that 2,400 intensive care beds would be needed, more than double the Dutch total capacity of 1,150.

Because the true death-rate was never revealed, the government’s failure to prepare adequately for a pandemic after a decade of its own austerity-led reductions in hospitals and medical staff never became a political issue.

While any attempt to misinform the public is roundly highlighted and mocked whenever Donald Trump engages in it, the misplaced reverence for European leaders has created a dangerous precedent where leaders are not being held to account for similar acts.

The false sense of confidence in Europe’s leaders could easily mean that even a second wave of infections will not lead to any significant criticism or consequences for the national leaders who used distorted data to justify a rush to reopen the economy.